Menu
Cart 0

BB Blog — Breast Cancer

Happy Mother's Day...

Posted by Emilienne Rebel on

Happy Mother's Day...

Wishing all mothers, grandmothers and women that care for others out there a wonderful Mother's Day. I hope its filled with love. 

My thoughts are also with those who are missing their mothers on this day more than most. 

I was diagnosed with Stage 3 Advanced Breast Cancer at the age of 31 when my two daughters were just three and nine months, so I've had to face the reality of not being there for them and that they wouldn't remember me (I found this thought abhorrent). 

I am so very grateful to share avery day and this years Mother's day with my girls. I am very blessed and I don't take a day for granted. I've been given the opportunity to teach them, love them and protect them and for that I am very grateful.  

This week we have sent out lots of Bold Beanies Bouquets (cancer hats rolled to look like roses and presented in a gift bouquet) and single chemo hats made into gift roses and this makes me happy... a gift that is not just beautiful and thoughtful, but practical too. 

Bold Beanies are soft cotton breathable cancer headwear designed with minimal fuss to be super comfortable and easy to wear. Wear during the day to be stylish and feel confident and get on with our day... or as a breathable night cap. Coming soon cotton stretchy cancer plain and Liberty scarves to layer over beanies or on their own. 

Read more →

Breakthrough Breast Cancer Drug gets NHS Approval

Posted by Emilienne Rebel on

Breakthrough Breast Cancer Drug gets NHS Approval

Two new "breakthrough" drugs to treat breast cancer have been given the green light for use on the NHS. The National Institute for Health and Care Excellence (NICE) approved palbociclib and ribociclib after negotiating prices for the treatments. Research shows the drugs slow down advanced cancer for at least 10 months and can delay the need for chemotherapy. Around 8,000 people in England will now have access to the medications. There are about 45,000 new diagnoses of breast cancer in the country each year. Palbociclib had earlier been rejected by NICE because of its high cost. One cycle of palbociclib...

Read more →